Literature DB >> 7905932

Examination for intratubular germ cell neoplasia at operation for undescended testis in boys.

D Cortes1, J Thorup, M Frisch, H Møller, G K Jacobsen, B L Beck.   

Abstract

A total of 843 consecutive boys (median age 12.7 years) who had undergone testicular biopsy at operation for undescended testis was followed into adulthood (median age 25.2 years) to examine for testicular germ cell neoplasia. Five cases of testicular germ cell neoplasia were identified, including 1 nonseminoma of the contralateral testis, which had been treated before surgery for an undescended testis, 1 nonseminoma found at followup, 1 seminoma and 2 intratubular germ cell neoplasms. Of the later 3 patients 1 had a 45,X/46,XY karyotype and 2 had abnormal external genitalia. Previous testicular biopsy from the patient in whom nonseminoma was noted at followup showed Sertoli cells only. We recommend that testicular biopsy be performed at operation for undescended testis in boys with abnormal sex chromosomes, particularly 45,X/46,XY karyotype, and in those with abnormal external genitalia. The pattern of Sertoli cells only in biopsies from boys does not preclude the occurrence of testicular cancer in adulthood.

Entities:  

Mesh:

Year:  1994        PMID: 7905932     DOI: 10.1016/s0022-5347(17)35071-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Testicular neoplasia in cryptorchid boys at primary surgery: case series.

Authors:  D Cortes; J Visfeldt; H Møller; J Thorup
Journal:  BMJ       Date:  1999-10-02

2.  Risk of testicular cancer with cryptorchidism and with testicular biopsy: cohort study.

Authors:  H Møller; D Cortes; G Engholm; J Thorup
Journal:  BMJ       Date:  1998-09-12

3.  Semen quality and gonadotropin levels in patients operated upon for cryptorchidism.

Authors:  J Mayr; H H Pusch; G Schimpl; T Reitinger; E Sorantin; M Mayr-Koci
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.